Patient SUCRC14 had no detectable ctDNA in follow-up plasma at day 192, confirming a normal CEA value on an earlier follow-up, and demonstrated no evidence of disease recurrence; suspected progression of disease on imaging at day 132 was deemed a false positive after a biopsy showed no evidence of tumor (Figure 3B). This evidence concerns the gene CEACAM5 and neoplasm.